BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31695154)

  • 1. Two types of primary mucinous ovarian tumors can be distinguished based on their origin.
    Simons M; Simmer F; Bulten J; Ligtenberg MJ; Hollema H; van Vliet S; de Voer RM; Kamping EJ; van Essen DF; Ylstra B; Schwartz LE; Wang Y; Massuger LF; Nagtegaal ID; Kurman RJ
    Mod Pathol; 2020 Apr; 33(4):722-733. PubMed ID: 31695154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Genetic Analysis of Ovarian Brenner Tumors and Associated Mucinous Epithelial Neoplasms: High Variant Concordance and Identification of Mutually Exclusive RAS Driver Mutations and MYC Amplification.
    Tafe LJ; Muller KE; Ananda G; Mitchell T; Spotlow V; Patterson SE; Tsongalis GJ; Mockus SM
    Am J Pathol; 2016 Mar; 186(3):671-7. PubMed ID: 26797085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A histogenetic consideration of ovarian mucinous tumors based on an analysis of lesions associated with teratomas or Brenner tumors.
    Nomura K; Aizawa S
    Pathol Int; 1997 Dec; 47(12):862-5. PubMed ID: 9503468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.
    Takeshima Y; Amatya VJ; Daimaru Y; Nakayori F; Nakano T; Inai K
    Hum Pathol; 2001 Nov; 32(11):1203-8. PubMed ID: 11727259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin.
    Wang Y; Wu RC; Shwartz LE; Haley L; Lin MT; Shih IeM; Kurman RJ
    J Pathol; 2015 Oct; 237(2):146-51. PubMed ID: 26095692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.
    Li XS; Sun J; He XL
    Genet Mol Res; 2015 Sep; 14(3):10752-9. PubMed ID: 26400304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis.
    Kuhn E; Ayhan A; Shih IeM; Seidman JD; Kurman RJ
    Mod Pathol; 2014 Feb; 27(2):231-7. PubMed ID: 23887305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Well-differentiated mucinous carcinoma of the ovary and a coexisting Brenner tumor both exhibit amplification of 12q14-21 by comparative genomic hybridization.
    Pejovic T; Bürki N; Odunsi K; Fiedler P; Achong N; Schwartz PE; Ward DC
    Gynecol Oncol; 1999 Jul; 74(1):134-7. PubMed ID: 10385566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors.
    Seidman JD; Khedmati F
    Arch Pathol Lab Med; 2008 Nov; 132(11):1753-60. PubMed ID: 18976011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.
    Anglesio MS; Kommoss S; Tolcher MC; Clarke B; Galletta L; Porter H; Damaraju S; Fereday S; Winterhoff BJ; Kalloger SE; Senz J; Yang W; Steed H; Allo G; Ferguson S; Shaw P; Teoman A; Garcia JJ; Schoolmeester JK; Bakkum-Gamez J; Tinker AV; Bowtell DD; Huntsman DG; Gilks CB; McAlpine JN
    J Pathol; 2013 Jan; 229(1):111-20. PubMed ID: 22899400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different staining patterns of ovarian Brenner tumor and the associated mucinous tumor.
    Roma AA; Masand RP
    Ann Diagn Pathol; 2015 Feb; 19(1):29-32. PubMed ID: 25596159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
    Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
    Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei.
    Ronnett BM; Seidman JD
    Am J Surg Pathol; 2003 May; 27(5):650-7. PubMed ID: 12717249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers.
    Genestie C; Auguste A; Al Battal M; Scoazec JY; Gouy S; Lacroix L; Morice P; Pautier P; Leary A; Devouassoux-Shisheboran M
    Virchows Arch; 2021 May; 478(5):885-891. PubMed ID: 33009577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.
    Baker PM; Oliva E; Young RH; Talerman A; Scully RE
    Am J Surg Pathol; 2001 May; 25(5):557-68. PubMed ID: 11342766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of 103 ovarian serous and mucinous tumors.
    Vereczkey I; Serester O; Dobos J; Gallai M; Szakács O; Szentirmay Z; Tóth E
    Pathol Oncol Res; 2011 Sep; 17(3):551-9. PubMed ID: 21136228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.